Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. | Pharmacol Rev | 2023 | 36753049 | PubTator, text mining | PubMed |
| Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4). | Nat Commun | 2023 | 36717591 | PubTator, text mining | PubMed |
| Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies. | Eur J Med Chem | 2023 | 36696766 | PubTator, text mining | PubMed |
| Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil. | Genes (Basel) | 2023 | 36672863 | PubTator, text mining | PubMed |
| Melatonin: Both a Messenger of Darkness and a Participant in the Cellular Actions of Non-Visible Solar Radiation of Near Infrared Light. | Biology (Basel) | 2023 | 36671781 | PubTator, text mining | PubMed |
| Kinin B1 Receptor Mediates Bidirectional Interaction between Neuroinflammation and Oxidative Stress. | Antioxidants (Basel) | 2023 | 36671012 | PubTator, text mining | PubMed |
| Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option. | Rev Assoc Med Bras (1992) | 2023 | 36629647 | PubTator, text mining | PubMed |
| Effectiveness and safety of four different beta-blockers in patients with chronic heart failure. | MedComm (2020) | 2023 | 36628295 | PubTator, text mining | PubMed |
| Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells. | Inflammopharmacology | 2023 | 36600055 | PubTator, text mining | PubMed |
| COVID-19 signalome: Potential therapeutic interventions. | Cell Signal | 2023 | 36521656 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Poxvirus Evolution. | mBio | 2023 | 36515529 | PubTator, text mining | PubMed |
| Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). | Eur Heart J Cardiovasc Pharmacother | 2023 | 36513329 | PubTator, text mining | PubMed |
| Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment. | Clin Drug Investig | 2023 | 36462104 | PubTator, text mining | PubMed |
| FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance. | Oncogene | 2023 | 36460773 | PubTator, text mining | PubMed |
| Successful Percutaneous Transhepatic Obliteration Plus Sengstaken-Blakemore Tube Combination Therapy for Recurrent Gastroesophageal Variceal Bleeding. | Intern Med | 2023 | 36328577 | PubTator, text mining | PubMed |
| Evolution of the orthopoxvirus core genome. | Virus Res | 2023 | 36280003 | PubTator, text mining | PubMed |
| Emergency pharmacology for the CT technologist. | J Med Radiat Sci | 2023 | 36149085 | PubTator, text mining | PubMed |
| Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions. | Anal Bioanal Chem | 2023 | 36102973 | PubTator, text mining | PubMed |
| Function and structure of bradykinin receptor 2 for drug discovery. | Acta Pharmacol Sin | 2023 | 36075965 | PubTator, text mining | PubMed |
| The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology. | Crit Rev Clin Lab Sci | 2023 | 35930434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=11